Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
17.7M
-
Shares change
-
-201K
-
Total reported value, excl. options
-
$105M
-
Value change
-
-$1.51M
-
Number of buys
-
17
-
Number of sells
-
-27
-
Price
-
$5.92
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q1 2024
71 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q1 2024.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.7M shares
of 92.4M outstanding shares and own 19.2% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (7.1M shares), Avoro Capital Advisors LLC (4M shares), FMR LLC (1.51M shares), VANGUARD GROUP INC (1.27M shares), BlackRock Inc. (1.11M shares), GEODE CAPITAL MANAGEMENT, LLC (449K shares), STATE STREET CORP (413K shares), NORTHERN TRUST CORP (199K shares), DEUTSCHE BANK AG\ (184K shares), and BML Capital Management, LLC (180K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.